Drug details

Lithostat (acetohydroxamic acid tablets)

type of Antimicrobials, Adjunct

Lithostat (acetohydroxamic acid) tablets are a urease inhibitor indicated as adjunctive therapy in patients with chronic urea-splitting urinary infection. AHA is intended to decrease urinary ammonia and alkalinity, but it should not be used in lieu of curative surgical treatment (for patients with stones) or antimicrobial treatment. Long-term treatment with AHA may be warranted to maintain urease inhibition as long as urea-splitting infection is present.

This drug may have the following side effects:

• nausea,
• palpitations,
• vomiting,
• skin rash,
• anemia,
• loss of appetite,
• nervousness,
• shaking,
• hair loss,
• feeling unwell (malaise),
• depression, and
• anxiety.
• mild headaches,
• sensation of warmth,
• phlebitis,